PROVIDER PROFILE · NPI 1669464723

Henry Legere

PRESCRIBING · PART D · 2024
Total Rx claims
126
Beneficiaries
—
Total drug cost
$109K
Distinct drugs
3
Brand share
100.0%
Top prescribed drugs
Tirzepatide90 claims
Ondansetron21 claims
Semaglutide15 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.